Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.
Musk and Bezos, two tech titans, reignite their rivalry over election claims, highlighting their competitive history in various sectors.
Gensler's resignation as SEC Chair signals a potential pro-crypto shift under Trump's administration, raising speculation about his successor and the future of crypto regulation.
Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.
Musk and Bezos, two tech titans, reignite their rivalry over election claims, highlighting their competitive history in various sectors.
Gensler's resignation as SEC Chair signals a potential pro-crypto shift under Trump's administration, raising speculation about his successor and the future of crypto regulation.